A detailed history of Certified Advisory Corp transactions in Amgen Inc stock. As of the latest transaction made, Certified Advisory Corp holds 1,460 shares of AMGN stock, worth $466,586. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,460
Previous 1,259 15.97%
Holding current value
$466,586
Previous $357,000 27.73%
% of portfolio
0.06%
Previous 0.05%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$262.75 - $319.31 $52,812 - $64,181
201 Added 15.97%
1,460 $456,000
Q1 2024

May 10, 2024

BUY
$268.87 - $324.56 $4,033 - $4,868
15 Added 1.21%
1,259 $357,000
Q4 2023

Feb 09, 2024

SELL
$255.7 - $288.46 $1.7 Million - $1.92 Million
-6,660 Reduced 84.26%
1,244 $358,000
Q3 2023

Nov 13, 2023

BUY
$218.65 - $271.46 $1.45 Million - $1.8 Million
6,628 Added 519.44%
7,904 $2.12 Million
Q2 2023

Aug 14, 2023

SELL
$214.27 - $253.37 $6,642 - $7,854
-31 Reduced 2.37%
1,276 $283,000
Q1 2023

May 15, 2023

SELL
$225.79 - $275.2 $212,242 - $258,688
-940 Reduced 41.83%
1,307 $315,000
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $7,099 - $9,021
31 Added 1.4%
2,247 $590,000
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $199,544 - $225,050
889 Added 66.99%
2,216 $500,000
Q2 2022

Aug 15, 2022

BUY
$230.71 - $256.74 $8,536 - $9,499
37 Added 2.87%
1,327 $323,000
Q3 2021

Nov 15, 2021

BUY
$212.27 - $248.7 $12,948 - $15,170
61 Added 4.96%
1,290 $274,000
Q1 2021

May 10, 2021

BUY
$221.91 - $258.6 $4,660 - $5,430
21 Added 1.74%
1,229 $306,000
Q2 2020

Jul 27, 2020

BUY
$197.81 - $242.74 $39,562 - $48,548
200 Added 19.84%
1,208 $285,000
Q2 2019

Aug 07, 2019

SELL
$166.7 - $195.41 $15,002 - $17,586
-90 Reduced 8.2%
1,008 $185,000
Q2 2018

Aug 14, 2018

SELL
$166.05 - $186.51 $4,815 - $5,408
-29 Reduced 2.57%
1,098 $202,000
Q1 2018

Apr 30, 2018

BUY
$169.43 - $198.0 $169,599 - $198,198
1,001 Added 794.44%
1,127 $191,000
Q4 2017

Feb 22, 2018

BUY
$168.79 - $188.59 $21,267 - $23,762
126
126 $21,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Certified Advisory Corp Portfolio

Follow Certified Advisory Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Certified Advisory Corp, based on Form 13F filings with the SEC.

News

Stay updated on Certified Advisory Corp with notifications on news.